{"disease":{"id":"cdd","name":"cdd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05558371","title":"International CDKL5 Clinical Research Network","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04486768","title":"International CDKL5 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT00340873","title":"Molecular Epidemiology of Dioxin-Related Illness in Seveso","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01383759","title":"Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT03861871","title":"Fenfluramine in CDKL5 Deficiency Disorder (CDD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"NYU Langone Health","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}